Single intracavernous injection of autologous adipose-derived stem cells versus a single high dose of Platelet Rich Plasma to improve erectile dysfunction: A comparative study
Not Applicable
Completed
- Conditions
- Erectile dysfunction
- Registration Number
- JPRN-UMIN000049397
- Lead Sponsor
- Al Zahraa Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
male with mild to moderate ED
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method effectiveness of single high dose PRP intracavernous injection and single dose of Adipose mesenchymal Stem Cells (ADSC) in patients with severe ED.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms by which adipose-derived stem cells improve erectile dysfunction in clinical trials?
How does the efficacy of intracavernous stem cell injection compare to standard-of-care treatments for erectile dysfunction?
Which biomarkers are associated with response to platelet-rich plasma therapy in patients with erectile dysfunction?
What are the potential adverse events of autologous stem cell injections for erectile dysfunction and how are they managed?
Are there combination therapies involving adipose-derived stem cells and PRP that enhance outcomes for erectile dysfunction?